Advice for Clinicians on Treating Patients with Prostate Cancer
Dr. Marc Matrana closes the discussion with considerations for clinicians on treating patients with prostate cancer.
Emerging Options and Advancements in the mCSPC Treatment Landscape
Insight on recent developments and emerging options in the mCSPC treatment landscape.
Strategies for Monitoring Patients with mCSPC During Therapy and Treating Patients After Disease Progression
An experienced clinician expands on effective strategies for monitoring patients with mCSPC during and after treatment and reviews patient expectations following disease progression.
Comparing Approved Options for Androgen Inhibition in the mCSPC Setting
Discussion centered around androgen receptor inhibition/androgen synthesis inhibition and comparison of available, approved options for each.
Selecting an Effective Treatment Approach Informed by Recent mCSPC Research
Clinical insights concerning the selection of effective treatment approaches for patients with mCSPC with comments on the study design and results of the TITAN study.
An Overview of First-line Therapy Options for Patients with mCSPC
A prostate cancer expert shares a brief overview of available first-line therapy options for patients with mCSPC.
Initial Impressions and Analysis of an mCSPC Patient Case
Marc Matrana, MD shares his perspective on an mCSPC patient case, focusing on the typical trajectory for patients with biochemical recurrence.
